Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

28 September 2026

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 29
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Ally Financial Earnings: Summer Doldrums Give Way To Long-Term Concerns (NYSE:ALLY)
News

Ally Financial Earnings: Summer Doldrums Give Way To Long-Term Concerns (NYSE:ALLY)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk21 July 20262 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Ally Financial Earnings: Summer Doldrums Give Way To Long-Term Concerns (NYSE:ALLY)
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

Vladimir Dimitrov, CFA is a former strategy consultant within the field of brand and intangible assets valuation. During his career in the City of London he has been working with some of the largest global brands within the technology, telecom and banking sectors. He graduated from the London School of Economics and is interested in finding reasonably priced businesses with sustainable long-term competitive advantages.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Please do your own due diligence and consult with your financial advisor, if you have one, before making any investment decisions. The author is not acting in an investment adviser capacity. The author’s opinions expressed herein address only select aspects of potential investment in securities of the companies mentioned and cannot be a substitute for comprehensive investment analysis. The author recommends that potential and existing investors conduct thorough investment research of their own, including a detailed review of the companies’ SEC filings. Any opinions or estimates constitute the author’s best judgment as of the date of publication and are subject to change without notice.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

Zymeworks Inc. (ZYME) M&A Call Transcript

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

Kinross Gold: The Pullback I Waited For Came With Damage Attached (NYSE:KGC)

Dividend Announcements: September 19-25, 2026

Editors Picks

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

'Chancellor John Healey's Budget will reveal winners and losers as hope meets reality next month'

28 September 2026

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

28 September 2026

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

28 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.